97 related articles for article (PubMed ID: 26571798)
1. [Sofosbuvir (Sovaldi), oral administration].
Duh D; Van Genechten D
J Pharm Belg; 2015 Mar; (1):61-3. PubMed ID: 26571798
[No Abstract] [Full Text] [Related]
2. Sofosbuvir and daclatasvir.
Hessel MH; Cohen AF; Rissmann R
Br J Clin Pharmacol; 2016 Sep; 82(3):878-9. PubMed ID: 27198488
[No Abstract] [Full Text] [Related]
3. Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection.
Childs-Kean LM; Hand EO
Clin Ther; 2015 Feb; 37(2):243-67. PubMed ID: 25601269
[TBL] [Abstract][Full Text] [Related]
4. Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis.
Soriano V; Barreiro P; de Mendoza C; Peña JM
Antivir Ther; 2016; 21(1):91-2. PubMed ID: 26042495
[TBL] [Abstract][Full Text] [Related]
5. [Not Available].
Stingl W
MMW Fortschr Med; 2015 Jun; 157 Suppl 2():55. PubMed ID: 26048126
[No Abstract] [Full Text] [Related]
6. Enter Sofosbuvir: The Path to Curing HCV.
Sofia MJ
Cell; 2016 Sep; 167(1):25-29. PubMed ID: 27634323
[No Abstract] [Full Text] [Related]
7. Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients.
Kahveci AS; Tahan V
Turk J Gastroenterol; 2016 Mar; 27(2):205-6. PubMed ID: 27015627
[No Abstract] [Full Text] [Related]
8. Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful sofosbuvir-based treatment.
Ruiz I; Feray C; Pawlotsky JM; Hézode C
Liver Transpl; 2015 Mar; 21(3):408-9. PubMed ID: 25420476
[No Abstract] [Full Text] [Related]
9. Acute liver failure during hepatitis C treatment with sofosbuvir and ledipasvir.
Debes JD; Ricci P
Dig Liver Dis; 2015 Dec; 47(12):1091-2. PubMed ID: 26427585
[No Abstract] [Full Text] [Related]
10. Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs.
Monoe C; Shimizu H; Kitaguchi K; Funakoshi H
Intern Med; 2020 Oct; 59(20):2619-2622. PubMed ID: 32611956
[TBL] [Abstract][Full Text] [Related]
11. Sofosbuvir-Induced Erythrodermic Pityriasis Rubra Pilaris-Like Drug Eruption.
Cheung EJ; Jedrych JJ; English JC
J Drugs Dermatol; 2015 Oct; 14(10):1161-2. PubMed ID: 26461830
[TBL] [Abstract][Full Text] [Related]
12. New medications for treatment of chronic hepatitis C.
Murfin M
JAAPA; 2015 Jul; 28(7):57-9. PubMed ID: 26107799
[TBL] [Abstract][Full Text] [Related]
13. Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir.
Syal G; Heldenbrand SD; Duarte-Rojo A
Am J Ther; 2016; 23(2):e570-1. PubMed ID: 25549078
[TBL] [Abstract][Full Text] [Related]
14. Sofosbuvir antiviral therapy in HCV patients with severe renal failure.
Rodríguez Gil FJ; Pérez Garrido I
Gastroenterol Hepatol; 2017 Feb; 40(2):85-86. PubMed ID: 26948178
[No Abstract] [Full Text] [Related]
15. In brief: severe bradycardia with sofosbuvir and amiodarone.
Med Lett Drugs Ther; 2015 Apr; 57(1466):58. PubMed ID: 25853664
[No Abstract] [Full Text] [Related]
16. Indian hepatitis C drug patent decision shakes public health community.
't Hoen EFM
Lancet; 2016 Jun; 387(10035):2272-2273. PubMed ID: 27238944
[No Abstract] [Full Text] [Related]
17. [Boceprevir (Victrelis), oral administration].
J Pharm Belg; 2012 Jun; (2):37-9. PubMed ID: 22978014
[No Abstract] [Full Text] [Related]
18. The rapid evolution of treatment strategies for hepatitis C.
Muir AJ
Am J Gastroenterol; 2014 May; 109(5):628-35; quiz 636. PubMed ID: 24732866
[TBL] [Abstract][Full Text] [Related]
19. Public funding for transformative drugs: the case of sofosbuvir.
Barenie RE; Avorn J; Tessema FA; Kesselheim AS
Drug Discov Today; 2021 Jan; 26(1):273-281. PubMed ID: 33011345
[TBL] [Abstract][Full Text] [Related]
20. The evolution of the therapeutic strategy in hepatitis C: features of sofosbuvir and indications.
Alberti A; Piovesan S
Dig Liver Dis; 2014 Dec; 46 Suppl 5():S174-8. PubMed ID: 25458777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
